Ticker
MRNA
Analysis
Moderna, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to MRNA.
Moderna, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to MRNA.
MRNA
Stock
$25.38B
Health Technology
Biotechnology
USD
Moderna, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
FDA Prescription Drug User Fee Act (PDUFA) goal date remains August 5, 2026 CAMBRIDGE, MA / ACCESS Newswire / June 18, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that th...
CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Science Day at 9:00am ET on Thursday, June 2...
Dr. Stephen Hoge, President of Moderna, to Assume an Expanded Role With Operational Oversight of the Company's Infectious Disease, Intismeran and Rare Disease Franchises Ester B...
Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome
eCommerce Powered by FFF Enterprises™ delivers an enhanced ordering experience for Moderna customers.TEMECULA, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc. — ...
Review valuation context for Moderna, Inc..
Review future growth context for Moderna, Inc..
Review past performance context for Moderna, Inc..
Review financial health context for Moderna, Inc..
Review dividend context for Moderna, Inc..
Review management context for Moderna, Inc..
Review ownership context for Moderna, Inc..
Review other information context for Moderna, Inc..
Review community context for Moderna, Inc..